Cargando…
Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
The introduction of selective COX-2 inhibitors (so-called ‘coxibs’) has demonstrated tremendous commercial success due to their claimed lower potential of serious gastrointestinal adverse effects than traditional NSAIDs. However, following the repeated questioning on safety concerns, the coxibs ‘con...
Autores principales: | El-Malah, Afaf A., Gineinah, Magdy M., Deb, Pran Kishore, Khayyat, Ahdab N., Bansal, Monika, Venugopala, Katharigatta N., Aljahdali, Anfal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318302/ https://www.ncbi.nlm.nih.gov/pubmed/35890126 http://dx.doi.org/10.3390/ph15070827 |
Ejemplares similares
-
Design, Synthesis, and Antipoliferative Activities of Novel Substituted Imidazole-Thione Linked Benzotriazole Derivatives
por: Khayyat, Ahdab N., et al.
Publicado: (2021) -
In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis
por: Deb, Pran Kishore, et al.
Publicado: (2021) -
Three-Dimensional In Vitro Cell Culture Models for Efficient Drug Discovery: Progress So Far and Future Prospects
por: Badr-Eldin, Shaimaa M., et al.
Publicado: (2022) -
Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4H-1,2,4-Triazole-3-Thiol and Its Schiff Bases: Computational Input and Molecular Dynamics
por: Venugopala, Katharigatta N., et al.
Publicado: (2020) -
Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls
por: Shinu, Pottathil, et al.
Publicado: (2022)